Mark Trusheim, MIT, to Present at GTCbio’s Inaugural Precision Medicine Conference

Boston, MA, June 13, 2016 --(PR.com)-- Mark Trusheim, Visiting Scientist of Applied Economics at the MIT Sloan School of Management, will give a presentation on “Implementing Precision Medicine, Determining Economic Value under Adaptive Biomedical Innovation Pathways” at GTCbio’s Inaugural Precision Medicine Conference to be held on July 7-8, 2016 in Boston, MA.

Precision medicines, increased regulatory pathway innovation (EMA Adaptive Pathways and FDA Breakthrough/Accelerated Approval), and evolving payer approaches stressing pay-for-performance transform the economics for innovators, patients and payers. Will these dynamics break the biomedical innovation chain or lead to a new sustainable path for all?

In this session, participants will explore how precision medicine and adaptive biomedical innovation pathways are transforming:

* Clinical development platforms, cost and speed
* Real world evidence use for determining clinical and economic value
* Market access timing, growth and pricing
* Capabilities to execute managed entry and pay-for-performance
* Application of precision medicine to legacy treatments as well as new

This conference brings together multiple stakeholders with a holistic view of the precision medicine landscape to discuss the future of healthcare. The summit will bring together an exciting balance of industry, academia, and government so that delegates have the unique opportunity to network with colleagues from different sectors and gain fresh perspective in precision medicine.

Session Topics:
I. Overcoming Challenges in the Commercialization of Precision Medicine
II. Implementation of Precision Medicine: Strategies & Technologies
III. Precision Medicine Beyond Oncology
IV. Integrating & Interpreting Personal Genomics, Big Data, & Bioinformatics
V. Incentivizing Precision Medicine: Regulation & Reimbursement

This conference is also part of their larger Molecular Diagnostics Summit, which includes two additional conferences:
Precision Medicine
2nd Cancer Markers & Liquid Biopsies
Digital PCR & qPCR

For more information, please visit website: www.gtcbio.com/precisionmedicine

GTCbio
635 W. Foothill Blvd
Monrovia, CA 91016
www.gtcbio.com/
Email: infogtcbio@gtcbio.com
Phone: (626) 256-6405
Fax: (626) 466-4433